Bradford, Kathryn L.
Moretti, Federico A.
Carbonaro-Sarracino, Denise A.
Gaspar, Hubert B.
Kohn, Donald B.
Funding for this research was provided by:
National Institutes of Health (P50-HL54850, P01-HL073104, U01-AI100801, R01-A1074043)
California Institute for Regenerative Medicine (UCLA-UCI Alpha Stem Cell Clinic)
Medical Research Council (MR/K015427/1)
National Institute for Health Research (Biomedical Research Centre)
Article History
Received: 5 February 2017
Accepted: 7 August 2017
First Online: 25 August 2017
Compliance with Ethical Standards
:
: DACS is an employee of Orchard Therapeutics Limited and DBK and HBG are members of the Scientific Advisory Board and consultants to Orchard Therapeutics, who are developing a commercial lentiviral vector gene therapy product.